A Long-Term Study of JNS020QD in Patients With Chronic Pain.

Trial Profile

A Long-Term Study of JNS020QD in Patients With Chronic Pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Jun 2013

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Janssen Pharmaceutical KK
  • Most Recent Events

    • 16 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Dec 2010 Planned End Date changed from 1 Nov 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
    • 28 Oct 2010 Trial start date changed from 1 Sep 2008 to 1 Nov 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top